Search results for "Anna"

showing 10 items of 1027 documents

Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impair…

2019

Abstract Background Obesity is a low-grade inflammation condition that facilitates the development of numerous comorbidities and the dysregulation of brain homeostasis. Additionally, obesity also causes distinct behavioral alterations both in humans and rodents. Here, we investigated the effect of inducible genetic deletion of the cannabinoid type 1 receptor (CB1) in adipocytes (Ati-CB1-KO mice) on obesity-induced memory deficits, depressive-like behavior, neuroinflammation and adult neurogenesis. Methods Behavioral, mRNA expression and immunohistochemical studies were performed in Ati-CB1-KO mice and corresponding wild-type controls under standard and high-fat diet. Results Adipocyte-speci…

Malemedicine.medical_specialtyCannabinoid receptorNeurogenesisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentInflammationDiet High-FatMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyNeural Stem CellsNeuritisReceptor Cannabinoid CB1AdipocyteInternal medicineAdipocytesmedicineAnimalsBiological PsychiatryNeuroinflammationMice KnockoutMemory DisordersBehavior AnimalDepressionEndocrine and Autonomic Systemsbusiness.industryNeurogenesisBrain030227 psychiatryAdult Stem CellsPsychiatry and Mental healthEndocrinologynervous systemchemistryGliosisOrgan SpecificityCannabinoidmedicine.symptombusinessGene Deletion030217 neurology & neurosurgeryHomeostasisPsychoneuroendocrinology
researchProduct

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice.

2007

Hypothalamic-pituitary-adrenocortical (HPA) axis hyperactivity is associated with major depressive disorders, and treatment with classical antidepressants ameliorates not only psychopathological symptoms, but also the dysregulation of the HPA axis. Here, we further elucidated the role of impaired cannabinoid type 1 receptor (CB1) signaling for neuroendocrine and behavioral stress coping in the mouse forced swim test (FST). We demonstrate that the genetic inactivation of CB1 is accompanied by increased plasma corticosterone levels both under basal conditions and at different time points following exposure to the FST. The latter effect could be mimicked in C57BL/6N mice by acute, subchronic, …

Malemedicine.medical_specialtyCannabinoid receptorTime FactorsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAntidepressive Agents TricyclicStatistics NonparametricArticlechemistry.chemical_compoundMiceEndocrinologyRimonabantPiperidinesReceptor Cannabinoid CB1CorticosteroneDesipramineInternal medicineCannabinoid receptor type 1Adaptation PsychologicalmedicineAnimalsBiological PsychiatrySwimmingMice KnockoutAnalysis of VarianceEndocrine and Autonomic SystemsDepressionDesipramineMice Inbred C57BLPsychiatry and Mental healthDisease Models AnimalEndocrinologychemistrynervous systemPyrazoleslipids (amino acids peptides and proteins)FemaleCannabinoidRimonabantPsychologyCorticosteronehuman activitiesGlucocorticoidStress Psychologicalmedicine.drugBehavioural despair testSignal TransductionPsychoneuroendocrinology
researchProduct

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.

2007

Dysregulation of the endocannabinoid system is known to interfere with emotional processing of stressful events. Here, we studied the role of cannabinoid receptor type 1 (CB1) signaling in stress-coping behaviors using the forced swim test (FST) with repeated exposures. We compared effects of genetic inactivation with pharmacological blockade of CB1 receptors both in male and female mice. In addition, we investigated potential interactions of the endocannabinoid system with monoaminergic and neurotrophin systems of the brain. Naive CB1 receptor-deficient mice (CB1-/-) showed increased passive stress-coping behaviors as compared to wild-type littermates (CB1+/+) in the FST, independent of se…

Malemedicine.medical_specialtyCannabinoid receptormedicine.medical_treatmentBiologyPharmacologyHippocampusMicePiperidinesReceptor Cannabinoid CB1Internal medicineCannabinoid receptor type 1MonoaminergicAdaptation PsychologicalGeneticsmedicineAnimalsBiogenic MonoaminesRNA MessengerReceptorMonoamine OxidaseSwimmingPharmacologyBrain-derived neurotrophic factormusculoskeletal neural and ocular physiologyBrain-Derived Neurotrophic FactorDesipraminefood and beveragesEndocannabinoid systemMice Inbred C57BLMonoamine neurotransmitterEndocrinologynervous systemVesicular Glutamate Transport Protein 1Molecular MedicinePyrazoleslipids (amino acids peptides and proteins)FemaleCannabinoidRimonabantpsychological phenomena and processesStress PsychologicalSignal TransductionThe pharmacogenomics journal
researchProduct

Who makes it all the way? Participants vs. decliners, and completers vs. drop-outs, in a 6-month exercise trial during cancer treatment : Results fro…

2022

Abstract Purpose To compare sociodemographic, health- and exercise-related characteristics of participants vs. decliners, and completers vs. drop-outs, in an exercise intervention trial during cancer treatment. Methods Patients with newly diagnosed breast, prostate, or colorectal cancer were invited to participate in a 6-month exercise intervention. Background data for all respondents (n = 2051) were collected at baseline by questionnaire and medical records. Additional data were collected using an extended questionnaire, physical activity monitors, and fitness testing for trial participants (n = 577). Moreover, a sub-group of decliners (n = 436) consented to additional data collection by a…

Malemedicine.medical_specialtyColorectal cancerPhysical activitylaw.inventionRandomized controlled triallawNeoplasmsSurveys and QuestionnairesAttritionmedicineÖvrig annan medicin och hälsovetenskapHumansExerciseSport and Fitness SciencesBehaviorCognitive Behavioral TherapyVDP::Medical disciplines: 700::Clinical medical disciplines: 750business.industryPhysical activityIdrottsvetenskapMedical recordFitness TestingPhysical activity; Oncology; Recruitment; Behavior; Health psychology; Attritionmedicine.diseaseOther Medical Sciences not elsewhere specifiedExercise TherapyCancer treatmentHealth psychologyHealth psychologyOncologyQuality of LifePhysical therapyAnxietyFemaleOriginal ArticleRecruitmentmedicine.symptombusiness
researchProduct

Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.

2004

The endogenous ligands of cannabinoid receptors, also known as endocannabinoids, have been implicated in many physiological and pathological processes of the central nervous system. Here we show that the levels of the two major endocannabinoids, anandamide and 2-arachidonoyl-glycerol (2-AG), in four areas of the rat brain, change dramatically between the light and dark phases of the day. While anandamide levels in the nucleus accumbens, pre-frontal cortex, striatum and hippocampus were significantly higher in the dark phase, the opposite was observed with 2-AG, whose levels were significantly higher during the light phase in all four regions. We found that the activity of the fatty acid ami…

Malemedicine.medical_specialtyDiacylglycerol lipaseCannabinoid receptorPolyunsaturated Alkamidesmedicine.medical_treatmentPhotoperiod2-ArachidonoylglycerolArachidonic AcidsAmidohydrolasesGlyceridesRats Sprague-DawleyCellular and Molecular Neurosciencechemistry.chemical_compoundFatty acid amide hydrolaseInternal medicineCannabinoid Receptor ModulatorsmedicineanandamideAnimals2-arachidonoylglycerol; anandamide; cannabinoid; circadian; faahMolecular BiologyPharmacologybiologyBrainCell BiologyAnandamidefaahcannabinoidEndocannabinoid system2-arachidonoylglycerolCircadian RhythmRatsMonoacylglycerol lipaseEndocrinologycircadianchemistryBiochemistrybiology.proteinMolecular MedicineCannabinoidEndocannabinoidsCellular and molecular life sciences : CMLS
researchProduct

Adolescent binge‐ethanol accelerates cognitive impairment and β‐amyloid production and dysregulates endocannabinoid signaling in the hippocampus of A…

2019

Previous research in rodents suggests that the long‐term neurobehavioral disturbances induced by chronic ethanol (EtOH) exposure could be due to endocannabinoid system (ECS) alterations. Moreover, ECS failure has been proposed to mediate the cognitive impairment and β‐amyloid production in Alzheimer disease (AD). Thus, in the present study, we evaluated the effects of adolescent EtOH binge drinking on the cognitive disturbances, hippocampal β‐amyloid levels, and in the ECS expression on a transgenic mouse model (APP/PSEN, AZ) of AD. We exposed AZ and wild‐type mice to a binge‐drinking treatment during adolescence. At 6 and 12 months of age, we evaluated hippocampal‐dependent learning and me…

Malemedicine.medical_specialtyDiacylglycerol lipasehippocampusmedicine.medical_treatmentMedicine (miscellaneous)HippocampusMice TransgenicHippocampusBinge DrinkingMice03 medical and health sciences0302 clinical medicineAlzheimer DiseaseInternal medicinemental disordersGene expressionmedicineAnimalsCognitive DysfunctionPharmacologyAmyloid beta-PeptidesEthanolbiologyWild typeendocannabinoidmedicine.diseaseEndocannabinoid systembinge drinkingMonoacylglycerol Lipases030227 psychiatryMonoacylglycerol lipaseDisease Models AnimalPsychiatry and Mental healthEndocrinologybiology.proteinβ‐amyloidadolescenceFemaleCannabinoidAlzheimer diseaseAlzheimer's disease030217 neurology & neurosurgeryEndocannabinoidsSignal TransductionAddiction Biology
researchProduct

Myocardial hypertrophy is associated with inflammation and activation of endocannabinoid system in patients with aortic valve stenosis.

2013

article i nfo Article history: Received 1 February 2013 Accepted 22 March 2013 Aims: Endocannabinoids and their receptors have been associated with cardiac adaptation to injury, inflam- mation and fibrosis. Experimental studies suggested a role for inflammatory reaction and active remodeling in myocardial hypertrophy, but they have not been shown in human hypertrophy. We investigated the asso- ciation of the endocannabinoid system with myocardial hypertrophy in patients with aortic stenosis. Main methods: Myocardial biopsies were collected from patients with aortic stenosis (AS) and atrial myxoma as controls during surgery. Histological and molecular analysis of endocannabinoids and their r…

Malemedicine.medical_specialtyInflammationCardiomegalyGeneral Biochemistry Genetics and Molecular BiologyMuscle hypertrophyFibrosisInternal medicinemedicineHumansGeneral Pharmacology Toxicology and PharmaceuticsAgedPressure overloadInflammationbiologybusiness.industryTenascin CGeneral MedicineAortic Valve Stenosismedicine.diseaseEndocannabinoid systemCTGFEndocrinologyAortic valve stenosisbiology.proteinlipids (amino acids peptides and proteins)Femalemedicine.symptombusinessEndocannabinoidsLife sciences
researchProduct

Chronic l-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats

2000

Abstract The effect of a unilateral 6-hydroxydopamine (6-OHDA) lesion of the left medial forebrain bundle and 3 weeks treatment with l -DOPA of normal and 6-OHDA lesioned rats on CB1r mRNA expression was investigated by in situ hybridization. A 6-OHDA lesion of nigrostriatal pathway alone, confirmed by the loss of nigral tyrosine hydroxylase mRNA, did not alter CB1r mRNA levels in the dopamine depleted striatum. Similarly, chronic l -DOPA treatment of normal rats had no effect on striatal CB1r mRNA expression. In contrast, chronic l -DOPA treatment of 6-OHDA-lesioned rats significantly increased CB1r mRNA expression in the denervated striatum. These results suggest that the CB1r activity ma…

Malemedicine.medical_specialtyLevodopaanimal structuresTyrosine 3-MonooxygenaseReceptors DrugDopamine Agents-DOPANigrostriatal pathwayStriatumBiologySubthalamic nucleusStriatumLevodopaLesionAdrenergic AgentsDopamineInternal medicinemedicineAnimalsRNA MessengerRats WistarOxidopamineReceptors CannabinoidMedial forebrain bundleHydroxydopamineTyrosine hydroxylaseGeneral NeuroscienceMedial Forebrain BundleParkinson DiseaseCorpus StriatumRatsmedicine.anatomical_structureEndocrinologynervous systemSettore BIO/14 - Farmacologiamedicine.symptomCannabinoid CB1 receptor mRNA6-Hydroxydopaminemedicine.drugNeuroscience Letters
researchProduct

Tobacco, Cannabis, and Other Illicit Drug Use Among Finnish Adolescent Twins: Causal Relationship or Correlated Liabilities?*

2010

Contains fulltext : 90566.pdf (Publisher’s version ) (Open Access) Objective: Among Finnish adolescent twins, we compared (a) a model that describes a direct impact of liability to tobacco use on cannabis and other illicit drug use with (b) a model that included a shared underlying liability for these substances. Furthermore, the extent to which genetic and environmental influences contribute to the covariation between liabilities to use these substances was examined. Method: Tobacco and illicit drug use were assessed at age 17.5 years. Twin data on 3,744 individuals were analyzed using standard biometrical methods. Two alternative multivariate models were fit and compared with Mx, a statis…

Malemedicine.medical_specialtyMarijuana AbuseHealth (social science)Recreational DrugAdolescentSubstance-Related DisordersTwinsMarijuana SmokingToxicologySocial EnvironmentCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineEnvironmental healthGenetic modelmental disordersmedicineIllicit drugHumans030212 general & internal medicinePsychiatryFinlandTobacco and other drugsbiologybusiness.industryIllicit DrugsSmokingAge FactorsTargeted interventionsbiology.organism_classificationmedicine.diseaseCausality3. Good healthSubstance abusePsychiatry and Mental healthFemaleCannabisbusinessDevelopmental Psychopathology030217 neurology & neurosurgeryResearch Article
researchProduct

Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes

2008

OBJECTIVE—Cannabinoid type 1 (CB1) receptor blockade decreases body weight and adiposity in obese subjects; however, the underlying mechanism is not yet fully understood. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) induces mitochondrial biogenesis and function in adipocytes. This study was undertaken to test whether CB1 receptor blockade increases the espression of eNOS and mitochondrial biogenesis in white adipocytes. RESEARCH DESIGN AND METHODS—We examined the effects on eNOS and mitochondrial biogenesis of selective pharmacological blockade of CB1 receptors by SR141716 (rimonabant) in mouse primary white adipocytes. We also examined eNOS expression and mitochondrial biog…

Malemedicine.medical_specialtyNitric Oxide Synthase Type IIIEndocrinology Diabetes and MetabolismAdipocytes WhiteImmunoblottingCitrate (si)-SynthaseWhite adipose tissueAMP-Activated Protein KinasesProtein Serine-Threonine KinasesMitochondrionDNA MitochondrialMicechemistry.chemical_compoundAdenosine TriphosphatePiperidinesReceptor Cannabinoid CB1AMP-activated protein kinaseMultienzyme ComplexesEnosAdipocyteInternal medicineInternal MedicinemedicineAnimalsPhosphorylationRNA Small InterferingReceptorCells CulturedDose-Response Relationship DrugbiologyReverse Transcriptase Polymerase Chain ReactionFlow Cytometrybiology.organism_classificationMitochondriaMice Inbred C57BLNitric oxide synthaseMetabolismEndocrinologychemistryMitochondrial biogenesisbiology.proteinSettore BIO/14 - FarmacologiaPyrazolesRimonabant
researchProduct